A Two-stage Simon Design Phase II Study for Non-BRCA MBC Patients With HRD Treated With Olaparib Single Agent
Clinical trial NCT03367689 · TERMINATED
Trial details
- NCT number
- NCT03367689
- Sponsor
- MedSIR
- Status
- TERMINATED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2018-04-17
- Primary completion
- 2021-07-31
- Enrollment
- 7
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.